norgestimate and ethinyl estradiol
norgestimate has been researched along with ethinyl estradiol in 92 studies
Research
Studies (92)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 8 (8.70) | 18.7374 |
1990's | 38 (41.30) | 18.2507 |
2000's | 36 (39.13) | 29.6817 |
2010's | 7 (7.61) | 24.3611 |
2020's | 3 (3.26) | 2.80 |
Authors
Authors | Studies |
---|---|
Lawson, JS; Osterman, JJ; Pasquale, SA; Yuliano, SE | 1 |
Gonzales-Ansorena, R; Rubio-Lotvin, B | 1 |
Abrams, LS; McGuire, JL; Patrick, JE; Weintraub, HS | 1 |
Anderson, FD | 1 |
Andolsek, KM | 1 |
Dain, MP; Gauthier, A; Upmalis, D | 1 |
Burkman, RT; Kafrissen, ME; Olson, W; Osterman, J | 1 |
Gillmer, MD | 1 |
Grunwald, K; Rabe, T; Runnebaum, B | 1 |
Huber, J | 1 |
Babor, P; Feichtinger, W; Herczeg, KM; Heyda, M; Hoffmann, R; Plöckinger, B; Steinhauser, B | 1 |
Back, DJ; Rudland, PS; Wild, MJ | 2 |
Chapdelaine, A; Derman, RJ; Desmarais, JL | 1 |
Back, DJ; Madden, S; Orme, ML | 1 |
Corson, SL | 1 |
Chez, RA | 1 |
Rabe, T; Runnebaum, B | 1 |
Lane, PA; Mayberry, DO; Young, RW | 1 |
Hull, ME; Moghissi, KS | 1 |
Borin, K; Moghissi, KS; Mohsenian, M | 1 |
Egarter, C; Huber, J; Putz, M; Speiser, P; Strohmer, H; Wenzl, R | 1 |
Jung-Hoffmann, C; Kuhl, H; Wiegratz, I | 1 |
Donnez, J; Grandjean, P; Lavenne, E; Schlit, AF | 1 |
Affinito, P; Di Carlo, C; Farace, MJ; Monterubbianesi, M; Nappi, C; Petrillo, G; Primizia, M; Regine, V | 1 |
Blode, H; Kuhnz, W; Mahler, M | 1 |
Andolsek, KM; Burkman, RT; Kafrissen, ME; Olson, W; Osterman, J | 1 |
Anderson, FD; Gillmer, MD | 1 |
Creatsas, G; Serfaty, D; Verougstraete, A; Wildemeersch, D | 1 |
Borm, GF; Coenen, CM; Rolland, R; Thomas, CM | 1 |
Teichmann, A | 1 |
Creinin, MD | 1 |
Lox, CD | 2 |
Handler, S; Huber, J; Kapiotis, S; Loner, U; Quehenberger, P; Schneider, B; Speiser, W | 1 |
Jones, TM; Jorizzo, JL; Kafrissen, ME; Lippman, JS; Olson, WH; Redmond, GP | 1 |
Stanczyk, FZ | 1 |
Henderson, TA; Lebwohl, M; Lucky, AW; Olson, WH; Robisch, DM; Swinyer, LJ | 1 |
Gross, W; Jung-Hoffmann, C; Kuhl, H; Wiegratz, I | 1 |
Redmond, GP | 1 |
Charkoudian, N; Johnson, JM | 1 |
Godwin, A; Lippman, J; Massaro, J; Siu, C; Sulak, P | 1 |
Chroust, K; Cibula, D; Horejsí, J; Paseka, J; Rotta, L; Unzeitig, V | 1 |
Andersen, LF; Christiansen, E; Jespersen, J; Madsbad, S; Petersen, KR; Skouby, SO | 1 |
Cusson, J; Heinemann, L; Lewis, M; Rainville, B; Spitzer, WO; Suissa, S | 1 |
Davis, A; Godwin, A; Kafrissen, M; Lippman, J; Olson, W | 1 |
Chroust, K; Cibula, D; Paseka, J; Unzeitig, V | 1 |
Bancroft, J; Bass, JL; Graham, CA; Sanders, SA | 1 |
Abrams, LS; Lasseter, KC; Natarajan, J; Skee, DM; Wong, FA | 1 |
Zieman, M | 1 |
Abrams, LS; Natarajan, J; Skee, D; Wong, FA | 1 |
Creinin, MD; Eder, SE; Godwin, AJ; Lippman, JS; Olson, W | 1 |
Taneepanichskul, S; Tantbirojn, P | 1 |
Abrams, LS; Allen, JG; Creasy, GW; Hammond, GL; Natarajan, J; Siiteri, PK | 1 |
Hönigsmann, H; Sator, PG; Schmidt, JB | 1 |
Eterović, D; Strinić, T | 1 |
Fisher, A; Friedman, A; Kafrissen, M; LaGuardia, KD; Shangold, G | 1 |
Friedman, AJ; Grinspoon, SK; Lippman, J; Miller, KK; Olson, WH; Warren, MP | 1 |
Kaunitz, AM | 1 |
del Marmol, V; Gertsen, K; Teichmann, A | 1 |
Baerwald, AR; Olatunbosun, OA; Pierson, RA | 1 |
Jain, JK; Stanczyk, FZ; White, T | 1 |
Friedman, AJ; Grinspoon, SK; Miller, KK; Olson, WH; Warren, MP | 1 |
O'Connell, KJ; Osborne, LM; Westhoff, C | 1 |
Jick, H; Jick, SS; Kaye, JA; Russmann, S | 1 |
Brenner, P | 1 |
Burrows, M; Peters, C | 1 |
Cole, JA; Doherty, M; Norman, H; Walker, AM | 1 |
Bettenhausen, DK; Connolly, M; Forbes, WP; Pentikis, H; Trapnell, CB | 1 |
Devineni, D; Janssens, L; LaGuardia, KD; Leung, AT; Massarella, J; Skee, D; Vaccaro, N | 1 |
Jick, H; Jick, S; Kaye, JA; Li, L | 1 |
Bancroft, J; Doll, HA; Graham, CA; Greco, T; Tanner, A | 1 |
Tan, JK | 1 |
Burkman, RT; Fisher, AC; LaGuardia, KD | 1 |
De Souza, MJ; VanHeest, JL; Vescovi, JD | 1 |
Badger, GJ; Cushman, M; Johnson, JV; Lowell, J; Rosing, J; Tchaikovski, S | 1 |
Barnowski, C; Hampton, RM; Wan, GJ; Zhang, HF | 1 |
Banárová, A; Koller, T; Kollerová, J; Ondrias, F; Payer, J | 1 |
Buono, MJ; Martin, JG | 1 |
Barnowski, CE; Burkman, RT; Fisher, AC; LaGuardia, KD; Wan, GJ | 1 |
Bertz, R; Eley, T; Garner, D; Krantz, K; Nettles, R; Persson, A; Sevinsky, H; Yones, C; Zhang, J | 1 |
Bertz, R; Chung, E; Eley, T; Mahnke, L; Persson, A; Xu, X; Yones, C; Zhang, J | 1 |
Cecchini, R; Gold, MA; Land, SR; Murray, PJ; Sucato, GS | 1 |
Backos, A; Bartlett, H; Callaghan, JH; Callaghan, MU; Chitlur, M; Marshall, S; Rajpurkar, M; Sawni, A; Zia, A | 1 |
Adeniji, AA; Cheang, KI; Essah, PA; Nestler, JE | 1 |
Chen, M; Huang, MQ; Kang, L; Lin, ZJ; Skee, D; Verhaeghe, T; Wang, W; Weng, N | 1 |
Fakayode, SO; Hordge, LN; Jones, DD; McDaniel, KL | 1 |
Chang, W; Dragoo, JL; Hsue, L; Konopka, JA; Thio, T | 1 |
Facchinetti, F; Grandi, G; Guariglia, G | 1 |
Bertz, RJ; Bhardwaj, R; Croop, RS; Morris, B; Stringfellow, JC | 1 |
Reviews
12 review(s) available for norgestimate and ethinyl estradiol
Article | Year |
---|---|
Selectivity and minimal androgenicity of norgestimate in monophasic and triphasic oral contraceptives.
Topics: Acne Vulgaris; Animals; Body Weight; Carbohydrates; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Lipids; Meta-Analysis as Topic; Norgestrel; Prolactin; Receptors, Androgen; Receptors, Progesterone; Sex Hormone-Binding Globulin | 1992 |
The European experience: an overview.
Topics: Contraceptives, Oral, Combined; Drug Combinations; Endometrium; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Europe; Female; Humans; Norgestrel; Progesterone Congeners | 1992 |
Gastrointestinal metabolism of contraceptive steroids.
Topics: Aged; Biological Availability; Contraceptives, Oral, Hormonal; Desogestrel; Ethinyl Estradiol; Female; Gastric Mucosa; Humans; Intestinal Mucosa; Male; Middle Aged; Norgestrel; Norpregnenes; Sulfates | 1990 |
Metabolic aspects of the new low-dose oral contraceptives.
Topics: Carbohydrate Metabolism; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Humans; Lipid Metabolism; Norgestrel; Norpregnenes; Proteins | 1989 |
Norgestimate: overview of a monophasic formulation.
Topics: Animals; Blood Coagulation; Carbohydrate Metabolism; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Drug Combinations; Endometrium; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Lipid Metabolism; Norgestrel; Ovulation; Progestins; Rabbits; Receptors, Androgen; Sex Hormone-Binding Globulin; Testosterone | 1993 |
Pharmacokinetics of the new progestogens and influence of gestodene and desogestrel on ethinylestradiol metabolism.
Topics: Desogestrel; Ethinyl Estradiol; Female; Humans; Kinetics; Norgestrel; Norpregnenes; Progesterone Congeners | 1997 |
Effectiveness of oral contraceptives in the treatment of acne.
Topics: Acne Vulgaris; Adolescent; Contraceptives, Oral; Ethinyl Estradiol; Female; Humans; Male; Norgestrel; Randomized Controlled Trials as Topic | 1998 |
Pharmacokinetic overview of Ortho Evra/Evra.
Topics: Administration, Cutaneous; Area Under Curve; Biological Availability; Contraceptives, Oral, Combined; Drug Combinations; Drug Delivery Systems; Ethinyl Estradiol; Ethisterone; Female; Half-Life; Humans; Norgestrel; Oximes | 2002 |
Enhancing oral contraceptive success: the potential of new formulations.
Topics: Chemistry, Pharmaceutical; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Humans; Norgestrel | 2004 |
The role of combined oral contraceptives in the management of acne and seborrhea.
Topics: Acne Vulgaris; Contraceptives, Oral; Contraceptives, Oral, Combined; Dermatitis, Seborrheic; Desogestrel; Ethinyl Estradiol; Female; Humans; Norgestrel; Norpregnenes; Safety; Treatment Outcome | 2004 |
New developments in hormonal therapy for acne.
Topics: Acne Vulgaris; Androstenes; Contraceptives, Oral, Hormonal; Cyproterone Acetate; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norgestrel | 2007 |
The role of combined oral contraceptives containing norgestimate for acne vulgaris treatment: a review.
Topics: Acne Vulgaris; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Norgestrel | 2023 |
Trials
50 trial(s) available for norgestimate and ethinyl estradiol
Article | Year |
---|---|
Optimum dosage of an oral contraceptive. A report from the study of seven combinations of norgestimate and ethinyl estradiol.
Topics: Adolescent; Adult; Clinical Trials as Topic; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Double-Blind Method; Drug Evaluation; Ethinyl Estradiol; Female; Gastrointestinal Diseases; Humans; Norgestrel; Pregnancy; Random Allocation; Uterine Hemorrhage | 1979 |
Cycle control with triphasic norgestimate and ethinyl estradiol, a new oral contraceptive agent.
Topics: Adolescent; Adult; Contraceptives, Oral, Combined; Dysmenorrhea; Ethinyl Estradiol; Female; Humans; Menstrual Cycle; Norgestrel; Patient Compliance; Premenstrual Syndrome | 1992 |
Clinical evaluation of a new triphasic oral contraceptive: norgestimate and ethinyl estradiol.
Topics: Adolescent; Adult; Blood Glucose; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Lipids; Menstrual Cycle; Norgestrel; Patient Compliance; Pregnancy | 1992 |
The efficacy and tolerability of norgestimate/ethinyl estradiol (250 micrograms of norgestimate/35 micrograms of ethinyl estradiol): results of an open, multicenter study of 59,701 women.
Topics: Adolescent; Adult; Blood Glucose; Cholesterol; Contraceptives, Oral, Combined; Drug Combinations; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Norgestrel; Triglycerides | 1992 |
Clinical experience with a new norgestimate-containing oral contraceptive.
Topics: Adult; Contraceptives, Oral, Combined; Drug Evaluation; Ethinyl Estradiol; Female; Humans; Menstrual Cycle; Norgestrel | 1991 |
[Side effects of oral contraceptives in the first treatment cycle].
Topics: Adult; Contraceptives, Oral, Combined; Desogestrel; Dose-Response Relationship, Drug; Ethinyl Estradiol; Female; Fertilization in Vitro; Humans; Norgestrel; Norpregnenes; Pilot Projects; Prospective Studies; Retrospective Studies | 1991 |
[Clinical evidence of the minimal androgenic activity of norgestimate].
Topics: Acne Vulgaris; Adult; Androgens; Clinical Trials as Topic; Ethinyl Estradiol; Female; Humans; Lipoproteins, HDL; Lipoproteins, LDL; Multicenter Studies as Topic; Norgestrel; Sex Hormone-Binding Globulin; Weight Gain | 1990 |
Efficacy and clinical profile of a new oral contraceptive containing norgestimate. U.S. clinical trials.
Topics: Adolescent; Adult; Cervix Mucus; Clinical Trials as Topic; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Glucose; Humans; Lipid Metabolism; Menstrual Cycle; Multicenter Studies as Topic; Norgestrel; Ovulation; Sex Hormone-Binding Globulin; United States | 1990 |
Ovarian function during low-dose oral contraceptive use.
Topics: Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Desogestrel; Dose-Response Relationship, Drug; Estradiol Congeners; Ethinyl Estradiol; Female; Humans; Norgestrel; Ovarian Cysts; Ovary; Patient Compliance; Progesterone; Prospective Studies; Smoking; Ultrasonography | 1995 |
Effect of two oral contraceptives containing ethinylestradiol and gestodene or norgestimate upon androgen parameters and serum binding proteins.
Topics: Adolescent; Adult; Androgens; Androstane-3,17-diol; Androstenedione; Carrier Proteins; Contraceptives, Oral; Contraceptives, Oral, Combined; Corticosterone; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Estradiol Congeners; Ethinyl Estradiol; Female; Humans; Hydrocortisone; Norgestrel; Norpregnenes; Radioimmunoassay; Sex Hormone-Binding Globulin; Testosterone | 1995 |
Large increase in plasmatic 11-dehydro-TxB2 levels due to oral contraceptives.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Analysis of Variance; Contraceptives, Oral; Ethinyl Estradiol; Factor VII; Factor VIII; Female; Fibrinogen; Humans; Levonorgestrel; Norethindrone; Norgestrel; Prothrombin; Thromboxane B2 | 1995 |
Efficacy, cycle control and side-effects of two monophasic combination oral contraceptives: gestodene/ethinylestradiol and norgestimate/ethinylestradiol.
Topics: Adult; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Italy; Menstrual Cycle; Norgestrel; Norpregnenes | 1993 |
Systemic availability of levonorgestrel after single oral administration of a norgestimate-containing combination oral contraceptive to 12 young women.
Topics: Adolescent; Adult; Biological Availability; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Half-Life; Humans; Levonorgestrel; Norgestrel | 1994 |
Metabolic effects and efficacy of a triphasic oral contraceptive (norgestimate/ethinyl estradiol).
Topics: Adult; Blood Glucose; Cholesterol; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Insulin; Lipids; Longitudinal Studies; Menstrual Cycle; Norgestrel; Triglycerides | 1993 |
Comparative evaluation of the androgenicity of four low-dose, fixed-combination oral contraceptives.
Topics: Adult; Androgens; Blood Pressure; Body Weight; Carrier Proteins; Contraceptives, Oral, Combined; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Desogestrel; Dihydrotestosterone; Dose-Response Relationship, Drug; Ethinyl Estradiol; Female; Humans; Hydroxyprogesterones; Norgestrel; Norpregnenes; Progesterone Congeners; Prospective Studies; Serum Albumin; Sex Hormone-Binding Globulin; Testosterone | 1995 |
Metabolic profile of six oral contraceptives containing norgestimate, gestodene, and desogestrel.
Topics: Adolescent; Adult; Cholesterol, HDL; Cholesterol, LDL; Contraceptives, Oral; Desogestrel; Dose-Response Relationship, Drug; Ethinyl Estradiol; Female; Humans; Lipid Metabolism; Lipids; Norgestrel; Norpregnenes; Progesterone Congeners | 1995 |
Biochemical effects in women following one year's exposure to a new triphasic contraceptive--I. chemistry profiles.
Topics: Adult; Blood Cell Count; Blood Chemical Analysis; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Contraceptives, Oral, Sequential; Ethinyl Estradiol; Female; Hematologic Tests; Humans; Norgestrel; Progestins; Women's Health | 1996 |
Biochemical effects in women following one year's exposure to a new triphasic contraceptive--II. coagulation profiles.
Topics: Adult; Blood Coagulation Factors; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Contraceptives, Oral, Sequential; Ethinyl Estradiol; Female; Humans; Norgestrel; Progestins; Protein C; Women's Health | 1996 |
Increased levels of activated factor VII and decreased plasma protein S activity and circulating thrombomodulin during use of oral contraceptives.
Topics: Adult; Blood Coagulation; Blood Proteins; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Contraceptives, Oral, Synthetic; Ethinyl Estradiol; Factor VIIa; Female; Humans; Norgestrel; Norpregnenes; Prospective Studies; Protein S; Risk Factors; Thromboembolism; Thrombomodulin | 1996 |
Norgestimate and ethinyl estradiol in the treatment of acne vulgaris: a randomized, placebo-controlled trial.
Topics: Acne Vulgaris; Adolescent; Adult; Drug Therapy, Combination; Estradiol Congeners; Ethinyl Estradiol; Female; Humans; Middle Aged; Norgestrel; Prospective Studies | 1997 |
Effectiveness of norgestimate and ethinyl estradiol in treating moderate acne vulgaris.
Topics: Acne Vulgaris; Adolescent; Adult; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Double-Blind Method; Drug Combinations; Ethinyl Estradiol; Female; Headache; Humans; Middle Aged; Nausea; Norgestrel; Patient Participation; Prospective Studies; Respiratory Tract Infections; Treatment Outcome | 1997 |
Effect of two oral contraceptives containing ethinyl estradiol and gestodene or norgestimate on different lipid and lipoprotein parameters.
Topics: Adolescent; Adult; Apolipoproteins B; Cholesterol; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Drug Evaluation; Ethinyl Estradiol; Female; Humans; Lipids; Lipoproteins; Norgestrel; Norpregnenes; Phospholipids; Reference Values; Triglycerides | 1998 |
Clinical comparison of triphasic norgestimate/35 micrograms ethinyl estradiol and monophasic norethindrone acetate/20 micrograms ethinyl estradiol. Cycle control, lipid effects, and user satisfaction.
Topics: Androgens; Contraception; Contraceptives, Oral, Synthetic; Drug Combinations; Ethinyl Estradiol; Female; Humans; Lipids; Menstrual Cycle; Norethindrone; Norethindrone Acetate; Norgestrel; Patient Satisfaction | 1999 |
An open label, randomized study to evaluate the effects of seven monophasic oral contraceptive regimens on hemostatic variables. Outline of the protocol. Oral Contraceptive and Hemostasis Study Group.
Topics: Blood Coagulation; Contraceptives, Oral; Desogestrel; Ethinyl Estradiol; Female; Fibrin Fibrinogen Degradation Products; Fibrinolysis; Hemostasis; Humans; Levonorgestrel; Norgestrel; Norpregnenes; Peptide Fragments; Prothrombin; Thrombin; Venous Thrombosis | 1999 |
[Clinical study of a triphasic contraceptive preparation (Norgestimate 180/215/250 micrograms + ethinylestradiol 35 micrograms) in a population of Czech women].
Topics: Adolescent; Adult; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Ethinyl Estradiol; Female; Humans; Norgestrel; Patient Satisfaction; Pregnancy; Prospective Studies | 1999 |
Metabolic and fibrinolytic response to changed insulin sensitivity in users of oral contraceptives.
Topics: Adult; Antibodies, Monoclonal; Blood Glucose; C-Peptide; Cardiovascular Diseases; Contraceptives, Oral, Synthetic; Diabetes Mellitus, Type 2; Enzyme-Linked Immunosorbent Assay; Ethinyl Estradiol; Female; Fibrinolysis; Glucose Tolerance Test; Humans; Insulin; Insulin Resistance; Norgestrel; Plasminogen Activator Inhibitor 1; Prospective Studies; Tissue Plasminogen Activator; Triglycerides | 1999 |
Triphasic norgestimate-ethinyl estradiol for treating dysfunctional uterine bleeding.
Topics: Adolescent; Adult; Contraceptives, Oral, Synthetic; Double-Blind Method; Ethinyl Estradiol; Female; Humans; Menstruation Disturbances; Middle Aged; Norgestrel; Treatment Outcome | 2000 |
[Liver function tests during administration of triphasic contraceptives containing Norgestimate].
Topics: Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Ethinyl Estradiol; Female; Humans; Liver Function Tests; Norgestrel; Prospective Studies | 2000 |
A prospective study of the effects of oral contraceptives on sexuality and well-being and their relationship to discontinuation.
Topics: Adult; Affect; Analysis of Variance; Attitude; Contraception; Contraceptives, Oral, Hormonal; Drug Administration Schedule; Ethinyl Estradiol; Female; Humans; Logistic Models; Marriage; Norgestrel; Prospective Studies; Sexuality; Surveys and Questionnaires; Time Factors | 2001 |
Multiple-dose pharmacokinetics of a contraceptive patch in healthy women participants.
Topics: Administration, Cutaneous; Adult; Analysis of Variance; Contraceptive Agents, Female; Drug Administration Schedule; Drug Combinations; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Middle Aged; Norgestrel; Oximes; Time Factors | 2001 |
The effect of extending the pill-free interval on follicular activity: triphasic norgestimate/35 micro g ethinyl estradiol versus monophasic levonorgestrel/20 micro g ethinyl estradiol.
Topics: Adolescent; Adult; Contraceptives, Oral, Synthetic; Estradiol; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Humans; Levonorgestrel; Luteinizing Hormone; Norgestrel; Ovarian Follicle; Patient Compliance; Progesterone | 2002 |
Clinical comparative study of oral contraceptives containing 30 microg ethinylestradiol/150 microg levonorgestrel, and 35 microg ethinylestradiol/250 microg norgestimate in Thai women.
Topics: Adolescent; Adult; Blood Pressure; Body Weight; Contraceptives, Oral; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Menstrual Cycle; Norgestrel; Thailand; Uterine Hemorrhage | 2002 |
Serum distribution of the major metabolites of norgestimate in relation to its pharmacological properties.
Topics: Adolescent; Adult; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Drug Combinations; Ethinyl Estradiol; Ethisterone; Female; Humans; Levonorgestrel; Norgestrel; Oximes; Serum Albumin; Sex Hormone-Binding Globulin; Testosterone | 2003 |
Efficacy, safety and cycle control of five oral contraceptive regimens containing norgestimate and ethinyl estradiol.
Topics: Adolescent; Adult; Contraceptives, Oral, Combined; Drug Combinations; Ethinyl Estradiol; Female; Humans; Menstrual Cycle; Norgestrel; Ovulation; Pregnancy; Progesterone; Racial Groups; Uterine Hemorrhage | 2003 |
Effects of a triphasic combination oral contraceptive containing norgestimate/ethinyl estradiol on biochemical markers of bone metabolism in young women with osteopenia secondary to hypothalamic amenorrhea.
Topics: Adolescent; Adult; Amenorrhea; Biomarkers; Bone and Bones; Bone Diseases, Metabolic; Bone Resorption; Cognition; Contraceptives, Oral, Combined; Double-Blind Method; Ethinyl Estradiol; Female; Gonadal Steroid Hormones; Humans; Hypothalamic Diseases; Norgestrel | 2003 |
Ovarian follicular development is initiated during the hormone-free interval of oral contraceptive use.
Topics: Adolescent; Adult; Contraceptives, Oral, Combined; Desogestrel; Drug Administration Schedule; Endometrium; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norgestrel; Ovarian Follicle; Treatment Outcome; Ultrasonography | 2004 |
Effect of oral versus transdermal steroidal contraceptives on androgenic markers.
Topics: Administration, Cutaneous; Adolescent; Adult; Androgens; Androstenedione; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Dehydroepiandrosterone Sulfate; Dihydrotestosterone; Drug Combinations; Ethinyl Estradiol; Ethisterone; Female; Humans; Norgestrel; Oximes; Sex Hormone-Binding Globulin; Testosterone; Treatment Outcome | 2005 |
Effects of an oral contraceptive (norgestimate/ethinyl estradiol) on bone mineral density in women with hypothalamic amenorrhea and osteopenia: an open-label extension of a double-blind, placebo-controlled study.
Topics: Absorptiometry, Photon; Adolescent; Adult; Amenorrhea; Biomarkers; Bone Density; Bone Diseases, Metabolic; Contraceptives, Oral, Synthetic; Double-Blind Method; Ethinyl Estradiol; Female; Humans; Hypothalamic Diseases; Lumbar Vertebrae; Norgestrel | 2005 |
Measured and reported weight change for women using a vaginal contraceptive ring vs. a low-dose oral contraceptive.
Topics: Administration, Intravaginal; Adolescent; Adult; Analysis of Variance; Body Mass Index; Contraceptive Devices, Female; Contraceptives, Oral, Synthetic; Desogestrel; Estrogens; Ethinyl Estradiol; Female; Humans; Norgestrel; Weight Gain | 2005 |
Androgenicity of the progestin in oral contraceptives does not affect maximal leg strength.
Topics: Adult; Androgens; Contraceptives, Oral, Combined; Ethinyl Estradiol; Exercise; Female; Humans; Leg; Levonorgestrel; Muscle Strength; Norgestrel; Progesterone Congeners; Progestins; Sports | 2006 |
Absence of effect of oral rifaximin on the pharmacokinetics of ethinyl estradiol/norgestimate in healthy females.
Topics: Administration, Oral; Adolescent; Adult; Anti-Bacterial Agents; Contraceptives, Oral, Combined; Cross-Over Studies; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Drug Interactions; Ethinyl Estradiol; Female; Humans; Middle Aged; Norgestrel; Rifamycins; Rifaximin; Therapeutic Equivalency | 2007 |
Pharmacokinetics and pharmacodynamics of a transdermal contraceptive patch and an oral contraceptive.
Topics: Abdomen; Administration, Cutaneous; Adolescent; Adult; Area Under Curve; Buttocks; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Cross-Over Studies; Drug Combinations; Ethinyl Estradiol; Female; Half-Life; Humans; Middle Aged; Norgestrel; Oximes | 2007 |
The effects of oral contraceptives on androgen levels and their relevance to premenstrual mood and sexual interest: a comparison of two triphasic formulations containing norgestimate and either 35 or 25 microg of ethinyl estradiol.
Topics: Adolescent; Adult; Affect; Androgens; Contraceptives, Oral, Combined; Dehydroepiandrosterone Sulfate; Ethinyl Estradiol; Female; Humans; Norgestrel; Premenstrual Syndrome; Sex Hormone-Binding Globulin; Sexual Behavior; Surveys and Questionnaires; Testosterone; Treatment Outcome | 2007 |
Effects of low-dose oral contraceptives on body weight: results of a randomized study of up to 13 cycles of use.
Topics: Adolescent; Adult; Body Weight; Contraception; Contraceptives, Oral; Desogestrel; Drug Combinations; Ethinyl Estradiol; Female; Humans; Menstrual Cycle; Middle Aged; Norethindrone; Norgestrel; Patient Satisfaction; Time Factors; Weight Gain | 2007 |
Short-term response of bone turnover to low-dose oral contraceptives in exercising women with hypothalamic amenorrhea.
Topics: Adult; Amenorrhea; Biomarkers; Bone and Bones; Bone Resorption; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Energy Intake; Energy Metabolism; Ethinyl Estradiol; Exercise; Female; Humans; Hypothalamic Diseases; Norgestrel; Peptide Fragments; Procollagen; Prospective Studies | 2008 |
Effects of oral and transdermal hormonal contraception on vascular risk markers: a randomized controlled trial.
Topics: Administration, Cutaneous; Adolescent; Adult; Analysis of Variance; Antithrombins; Blood Coagulation; Blood Proteins; C-Reactive Protein; Contraceptives, Oral, Hormonal; Cross-Over Studies; Drug Combinations; Ethinyl Estradiol; Factor VIII; Female; Fibrinogen; Humans; Norgestrel; Oximes; Protein S; Risk Factors; Thrombosis; von Willebrand Factor | 2008 |
Bleeding patterns with monophasic and triphasic low-dose ethinyl estradiol combined oral contraceptives.
Topics: Adolescent; Adult; Age Factors; Body Weight; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Estrogens; Ethinyl Estradiol; Female; Humans; Menstruation; Metrorrhagia; Middle Aged; Norethindrone; Norgestrel; Retrospective Studies; Treatment Outcome | 2008 |
Oral contraceptives elevate core temperature and heart rate during exercise in the heat.
Topics: Adult; Body Temperature; Body Temperature Regulation; Contraceptives, Oral; Desogestrel; Drug Combinations; Drug Therapy, Combination; Ethinyl Estradiol; Exercise; Female; Heart Rate; Hot Temperature; Humans; Levonorgestrel; Luteal Phase; Mestranol; Norethindrone; Norgestrel; Skin Temperature | 1997 |
Association between efficacy and body weight or body mass index for two low-dose oral contraceptives.
Topics: Adolescent; Adult; Body Mass Index; Body Weight; Contraceptives, Oral; Ethinyl Estradiol; Female; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Norgestrel; Pregnancy; Pregnancy, Unplanned; Proportional Hazards Models; Retrospective Studies; Risk; Young Adult | 2009 |
Effects of rimegepant 75 mg daily on the pharmacokinetics of a combined oral contraceptive containing ethinyl estradiol and norgestimate in healthy female participants.
Topics: Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Pyridines | 2023 |
Other Studies
30 other study(ies) available for norgestimate and ethinyl estradiol
Article | Year |
---|---|
Experience with a new low dose oral contraceptive: norgestimate & ethinyl estradiol.
Topics: Adult; Contraceptives, Oral; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Menstruation; Norgestrel | 1978 |
Disposition of norgestimate in the presence and absence of ethinyl estradiol after oral administration to humans.
Topics: Administration, Oral; Drug Combinations; Drug Interactions; Ethinyl Estradiol; Female; Humans; Intestinal Absorption; Kinetics; Norgestrel | 1978 |
Lipid and carbohydrate effects of a new triphasic oral contraceptive containing norgestimate.
Topics: Adolescent; Adult; Blood Glucose; Carbohydrates; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Insulin; Lipids; Norgestrel | 1992 |
Metabolism of the oral contraceptive steroids ethynylestradiol and norgestimate by normal (Huma 7) and malignant (MCF-7 and ZR-75-1) human breast cells in culture.
Topics: Breast; Breast Neoplasms; Cell Line; Contraceptives, Oral; Estradiol; Estrone; Ethinyl Estradiol; Female; Humans; Norgestrel; Radioisotope Dilution Technique; Tritium; Tumor Cells, Cultured | 1991 |
New progestogens in oral contraceptives.
Topics: Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Glucose; Glucose Tolerance Test; Humans; Insulin; Levonorgestrel; Lipids; Lipoproteins; Norgestrel; Norpregnenes; Progesterone Congeners | 1987 |
Determination of norgestimate and ethinyl estradiol in tablets by high-performance liquid chromatography.
Topics: Drug Stability; Ethinyl Estradiol; Norgestrel; Tablets | 1987 |
Effects of norgestimate (0.250 mg) in combination with ethinyl estradiol (0.035 mg) on cervical mucus.
Topics: Adolescent; Adult; Cervix Mucus; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Norgestrel | 1986 |
Effects of norgestimate in combination with ethinyl estradiol on cervical mucus.
Topics: Adolescent; Adult; Body Temperature; Cervix Mucus; Ethinyl Estradiol; Female; Humans; Male; Menstruation; Norgestrel; Spermatozoa | 1981 |
Metabolism of the oral contraceptive steroids ethynylestradiol, norgestimate and 3-ketodesogestrel by a human endometrial cancer cell line (HEC-1A) and endometrial tissue in vitro.
Topics: Chromatography, High Pressure Liquid; Contraceptives, Oral, Hormonal; Desogestrel; Endometrial Neoplasms; Endometrium; Estradiol; Estrone; Ethinyl Estradiol; Female; Humans; Kinetics; Norgestrel; Tumor Cells, Cultured | 1993 |
European Society of Contraception oral contraceptives survey update: birth control methods in "Europe of the 12".
Topics: Adult; Aging; Cardiovascular Diseases; Contraception; Contraceptives, Oral; Data Collection; Desogestrel; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Estradiol Congeners; Ethinyl Estradiol; Europe; Female; Humans; Levonorgestrel; Norgestrel; Norpregnenes; Progesterone; Progesterone Congeners; Risk Factors; Smoking; Surveys and Questionnaires | 1995 |
Laboratory criteria for menopause in women using oral contraceptives.
Topics: Adult; Aged; Contraceptives, Oral; Desogestrel; Drug Combinations; Estradiol; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Menopause; Middle Aged; Norgestrel; Pilot Projects; Prospective Studies; Time Factors | 1996 |
Altered reflex control of cutaneous circulation by female sex steroids is independent of prostaglandins.
Topics: Adult; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Cyclooxygenase Inhibitors; Drug Combinations; Estradiol Congeners; Female; Heart Rate; Hot Temperature; Humans; Ibuprofen; Mestranol; Norethindrone; Norgestrel; Prostaglandins; Reflex; Skin; Stress, Physiological; Sweating; Vasodilation | 1999 |
Recurrent use of newer oral contraceptives and the risk of venous thromboembolism.
Topics: Adult; Body Mass Index; Case-Control Studies; Contraceptives, Oral, Synthetic; Desogestrel; Estrogens; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Logistic Models; Norgestrel; Norpregnenes; Risk Factors; Venous Thrombosis | 2000 |
The introduction of a transdermal hormonal contraceptive (Ortho Evra/Evra).
Topics: Administration, Cutaneous; Contraceptives, Oral, Combined; Drug Combinations; Drug Delivery Systems; Estrogens; Ethinyl Estradiol; Ethisterone; Female; Humans; Norgestrel; Oximes; Progestins | 2002 |
Clinical evidence of the endocrinological influence of a triphasic oral contraceptive containing norgestimate and ethinyl estradiol in treating women with acne vulgaris. A pilot study.
Topics: Acne Vulgaris; Adolescent; Adult; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Estradiol Congeners; Ethinyl Estradiol; Female; Humans; Norgestrel; Pilot Projects; Prospective Studies; Treatment Outcome | 2003 |
Less estrogen in new oral contraceptive.
Topics: Acne Vulgaris; Adult; Contraceptives, Oral, Combined; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Norgestrel | 2003 |
Oral contraceptives improve lung mechanics.
Topics: Adult; Contraceptives, Oral; Ethinyl Estradiol; Female; Forced Expiratory Volume; Humans; Norgestrel; Respiratory Mechanics | 2003 |
Risk of nonfatal venous thromboembolism in women using a contraceptive transdermal patch and oral contraceptives containing norgestimate and 35 microg of ethinyl estradiol.
Topics: Administration, Cutaneous; Adolescent; Adult; Case-Control Studies; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Estrogens; Ethinyl Estradiol; Female; Humans; Norgestrel; Risk Factors; Thromboembolism | 2006 |
Risk of nonfatal venous thromboembolism in women using a contraceptive transdermal patch and oral contraceptives containing norgestimate and 35 microg of ethinyl estradiol.
Topics: Administration, Cutaneous; Adolescent; Adult; Contraceptive Agents; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Longitudinal Studies; Norgestrel; Pregnancy; Risk; Thromboembolism | 2006 |
Venous thromboembolism, myocardial infarction, and stroke among transdermal contraceptive system users.
Topics: Administration, Cutaneous; Brain Ischemia; Case-Control Studies; Cohort Studies; Contraceptives, Oral; Drug Combinations; Ethinyl Estradiol; Female; Humans; Incidence; Myocardial Infarction; Norgestrel; Stroke; Thromboembolism; Venous Thrombosis | 2007 |
Further results on the risk of nonfatal venous thromboembolism in users of the contraceptive transdermal patch compared to users of oral contraceptives containing norgestimate and 35 microg of ethinyl estradiol.
Topics: Administration, Cutaneous; Administration, Oral; Adolescent; Adult; Case-Control Studies; Contraceptive Agents, Female; Databases, Factual; Ethinyl Estradiol; Female; Humans; Managed Care Programs; Norgestrel; Risk Factors; Thromboembolism; United States | 2007 |
[Acute cholestasis following treatment with nimesulide and oral contraception: case report and review].
Topics: Acute Disease; Adult; Anti-Inflammatory Agents, Non-Steroidal; Cholestasis; Contraceptives, Oral, Synthetic; Cyclooxygenase Inhibitors; Drug Interactions; Ethinyl Estradiol; Female; Humans; Liver; Norgestrel; Sulfonamides | 2008 |
The effect of efavirenz on the pharmacokinetics of an oral contraceptive containing ethinyl estradiol and norgestimate in healthy HIV-negative women.
Topics: Adolescent; Adult; Alkynes; Anti-HIV Agents; Area Under Curve; Benzoxazines; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Cyclopropanes; Drug Interactions; Estrogens; Ethinyl Estradiol; Female; Humans; Norgestrel; Reverse Transcriptase Inhibitors; Young Adult | 2011 |
The effect of atazanavir/ritonavir on the pharmacokinetics of an oral contraceptive containing ethinyl estradiol and norgestimate in healthy women.
Topics: Adult; Anti-HIV Agents; Atazanavir Sulfate; Contraceptives, Oral, Combined; Drug Combinations; Drug Interactions; Drug Therapy, Combination; Ethinyl Estradiol; Female; Humans; Middle Aged; Norgestrel; Oligopeptides; Pyridines; Ritonavir; Women's Health; Young Adult | 2011 |
Adolescents' experiences using the contraceptive patch versus pills.
Topics: Adolescent; Affect; Contraceptive Agents, Female; Contraceptives, Oral; Estrogens; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Longitudinal Studies; Menstruation; Norgestrel; Patient Satisfaction; Prospective Studies; Quality of Life; Surveys and Questionnaires; Transdermal Patch; Young Adult | 2011 |
Hypercoagulability in adolescent girls on oral contraceptives-global coagulation profile and estrogen receptor polymorphisms.
Topics: Adolescent; Blood Coagulation; Blood Coagulation Tests; Contraceptives, Oral; Estrogen Receptor alpha; Ethinyl Estradiol; Factor V; Factor VIII; Female; Gene Expression; Heterozygote; Homozygote; Humans; Norgestrel; Polymorphism, Single Nucleotide; Protein S; Thrombin; Thrombomodulin; Thrombophilia; von Willebrand Factor; Young Adult | 2015 |
Metabolic Effects of a Commonly Used Combined Hormonal Oral Contraceptive in Women With and Without Polycystic Ovary Syndrome.
Topics: Adult; Blood Glucose; Carbohydrates; Case-Control Studies; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Dose-Response Relationship, Drug; Estrogens; Ethinyl Estradiol; Female; Glucose Tolerance Test; Gonadal Steroid Hormones; Humans; Insulin; Lipid Metabolism; Lipids; Norgestrel; Polycystic Ovary Syndrome | 2016 |
UPLC-MS/MS assay for the simultaneous determination of ethinyl estradiol, norgestimate and 17-Desacetyl norgestimate at low pg/mL in human plasma.
Topics: Chromatography, Liquid; Ethinyl Estradiol; Humans; Norgestrel; Quality Control; Reference Standards; Tandem Mass Spectrometry | 2016 |
Simultaneous determination of estrogens (ethinylestradiol and norgestimate) concentrations in human and bovine serum albumin by use of fluorescence spectroscopy and multivariate regression analysis.
Topics: Animals; Cattle; Estrogens; Ethinyl Estradiol; Humans; Least-Squares Analysis; Multivariate Analysis; Norgestrel; Serum Albumin, Bovine; Spectrometry, Fluorescence; Time Factors | 2016 |
The Effect of Oral Contraceptive Hormones on Anterior Cruciate Ligament Strength.
Topics: Androstenes; Animals; Anterior Cruciate Ligament; Biomechanical Phenomena; Contraceptives, Oral; Estrogens; Ethinyl Estradiol; Ethynodiol Diacetate; Female; Norethindrone; Norgestrel; Progestins; Rats; Rats, Sprague-Dawley | 2020 |